Pentagon Study Finds Higher Cancer Rates Among Pilots, Ground Crews
Military pilots and the ground crews who fuel and maintain their aircraft have higher rates of certain cancers, a new study shows.
Brain Cancer News
BRAIN CANCER ADVISOR
Brain Cancer News
Adverse Birth Outcomes More Common Among AYAs With Cancer During Pregnancy
Adolescent and young adult patients diagnosed with cancer during pregnancy have a higher risk of adverse birth outcomes, a study suggests.
Tafinlar Plus Mekinist Approved for Pediatric BRAF V600E Low-Grade Glioma
The FDA approved the combination to treat pediatric patients 1 year of age and older who have low-grade glioma with a BRAF V600E mutation and require systemic therapy.
Artificial Intelligence Can Predict Cancer Survival Using Data From a Single Consultation
Artificial intelligence can predict survival in cancer patients using information from a patient’s initial consultation with an oncologist, a study suggests.
Unemployment Linked to Higher Symptom Burden in Patients With CNS Tumors
Patients who were unemployed due to a CNS tumor reported more functional impairment with walking, washing, dressing, and performing usual activities.
Interferon Alfa Improves Upon Standard Care in High Grade Glioma
Adding interferon alfa to treatment with temozolomide and radiotherapy prolongs survival in patients with newly diagnosed, high grade glioma, a phase 3 trial suggests.
Childhood, Adolescent Cancers Linked to Higher Risk of Major Psychiatric Disorders
Compared with the general population, survivors of childhood and adolescent cancers have an increased risk of 6 major psychiatric disorders.
Extent of Tumor Resection Linked to Long-Term Survival in Grade 2 Glioma
More complete tumor resection is associated with improved long-term outcomes in patients with IDH-mutant, grade 2 glioma.
Patients Undergoing Cancer Surgery Have Higher Risk of Suicide
Patients undergoing cancer surgery have an increased risk of suicide compared with the general population, a new study suggests.
Hippocampal-Sparing Radiation May Be Feasible in Pediatric Medulloblastoma
Research suggests hippocampal-sparing radiation may be feasible for pediatric patients with medulloblastoma because the risk of peri‐hippocampal recurrence is low.
Investigational Therapy Gets Fast Track Status for Glioblastoma Multiforme
In mouse models, WP1122 outperformed temozolomide.
Convection-Enhanced Delivery of Topotecan Active in Glioblastoma
Chronic convection-enhanced delivery of topotecan was feasible and well tolerated in patients with recurrent glioblastoma.
Cancer-Related Mortality Tied to Residential Segregation
Residential racial and economic segregation across US counties is associated with higher cancer mortality, a study suggests.
Dendritic Cell Vaccine Improves Upon Standard Care for Glioblastoma
Adding an autologous tumor lysate-loaded dendritic cell vaccine to standard care improves survival in patients with glioblastoma, a phase 3 study suggests.
Pediatric Cancer Survivors Experience Premature Aging
Young adult survivors of pediatric cancer experience significant premature aging, a retrospective study suggests.
Most Phase 3 Trials of Newly Diagnosed Glioblastoma Show No Improvement in OS
Most recent phase 3 trials of patients with newly diagnosed glioblastoma have shown no significant improvement in overall survival with the experimental treatment.
Deaths on the Rise in Patients With Malignant Brain Tumors
Deaths among patients with primary malignant brain tumors are on the rise in the United States, data suggest.
Risk of COVID-19 and Poor Outcomes Not Increased Among Glioma Patients
Patients with glioma do not have an increased risk of SARS-CoV-2 infection or worse outcomes from COVID-19, a single-center study suggests.
Neuroophthalmological Late Effects Common in Pediatric/Adolescent Medulloblastoma
Children and adolescents with medulloblastoma frequently suffer from neuroophthalmological sequelae, a single-center study suggests.
Predicting Outcomes of Regorafenib in Patients With Recurrent Glioblastoma
Researchers say they have identified a molecular signature that can be used to predict outcomes of regorafenib treatment in patients with recurrent glioblastoma.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...